Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2015-04-01 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE VAUDREUIL (27100), Eure
PHARMACIE DU VAUDREUIL : revenue, balance sheet and financial ratios
PHARMACIE DU VAUDREUIL is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE VAUDREUIL (27100),
this company of category PME
shows in 2023 a revenue of 2.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU VAUDREUIL (SIREN 810770107)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
2 419 037 €
2 190 180 €
2 138 772 €
N/C
N/C
N/C
N/C
N/C
Net income
166 128 €
146 865 €
163 714 €
106 226 €
58 962 €
133 215 €
94 583 €
75 062 €
48 944 €
68 839 €
EBITDA
N/C
N/C
232 497 €
166 483 €
126 660 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
6.8%
4.9%
2.8%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DU VAUDREUIL generates positive net income of 166 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 69 k€ -> 166 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
166 128 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 82%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
81.843%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.532%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU VAUDREUIL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
969.769
717.328
475.657
344.142
229.315
205.383
163.429
119.076
100.382
81.843
Financial autonomy
8.004
10.69
14.898
19.974
26.829
29.163
32.501
39.553
43.808
48.532
Repayment capacity
None
None
None
None
None
20.444
9.863
5.757
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
2.722%
5.189%
7.263%
None%
None%
Sector positioning
Debt ratio
81.842025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average
In 2025, the debt ratio of PHARMACIE DU VAUDREUIL (81.84) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.53%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average
In 2025, the financial autonomy of PHARMACIE DU VAUDREUIL (48.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
5.76 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE DU VAUDREUIL (5.76) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 172.49. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
172.485
Liquidity indicators evolution PHARMACIE DU VAUDREUIL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
138.039
135.154
111.854
138.24
123.511
171.884
149.648
168.218
169.966
172.485
Interest coverage
None
None
None
None
None
5.163
12.175
3.273
None
None
Sector positioning
Liquidity ratio
172.492025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average+5 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DU VAUDREUIL (172.49) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
3.27x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of PHARMACIE DU VAUDREUIL (3.3x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU VAUDREUIL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
286 574 €
241 883 €
198 337 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
31
31
26
0
0
Customer payment term (days)
0
0
0
0
0
9
10
7
0
0
Supplier payment term (days)
0
0
0
0
0
37
50
42
0
0
Positioning of PHARMACIE DU VAUDREUIL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU VAUDREUIL is estimated at
2 638 963 €
(range 1 790 812€ - 4 140 896€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1790k€2638k€4140k€
2 638 963 €Range: 1 790 812€ - 4 140 896€
NAF 5 année 2025
Valuation method used
Net Income Multiple
166 128 €
×
15.9x
=2 638 963 €
Range: 1 790 813€ - 4 140 896€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU VAUDREUIL with other companies in the same sector:
Frequently asked questions about PHARMACIE DU VAUDREUIL
What is the revenue of PHARMACIE DU VAUDREUIL ?
The revenue of PHARMACIE DU VAUDREUIL in 2023 is 2.4 M€.
Is PHARMACIE DU VAUDREUIL profitable?
Yes, PHARMACIE DU VAUDREUIL generated a net profit of 166 k€ in 2025.
Where is the headquarters of PHARMACIE DU VAUDREUIL ?
The headquarters of PHARMACIE DU VAUDREUIL is located in LE VAUDREUIL (27100), in the department Eure.
Where to find the tax return of PHARMACIE DU VAUDREUIL ?
The tax return of PHARMACIE DU VAUDREUIL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU VAUDREUIL operate?
PHARMACIE DU VAUDREUIL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart